Cargando…

The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinoma

BACKGROUND: The predictive value of vessels encapsulating tumor clusters (VETC) in recurrent early‐stage hepatocellular carcinoma (HCC) remains unclear. Therefore, the aim of the present study was to investigate the prognostic significance of VETC in patients with recurrent early‐stage HCC after rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhi‐Yuan, Guo, Zhi‐Xing, Lu, Liang‐He, Mei, Jie, Lin, Wen‐Ping, Li, Shao‐Hua, Wei, Wei, Guo, Rong‐Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366089/ https://www.ncbi.nlm.nih.gov/pubmed/34212527 http://dx.doi.org/10.1002/cam4.4102

Ejemplares similares

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
por: Lu, Liang‐He, et al.
Publicado: (2020)

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma
por: Mei, Jie, et al.
Publicado: (2019)

Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma
por: Guan, Renguo, et al.
Publicado: (2022)

Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma
por: Liu, Ken, et al.
Publicado: (2023)

Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
por: Dennis, Claude, et al.
Publicado: (2022)

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
por: Shi, Ji‐Hua, et al.
Publicado: (2019)

Vessels That Encapsulate Tumor Clusters (VETC) Predict cTACE Response in Hepatocellular Carcinoma
por: Lin, Chunyu, et al.
Publicado: (2023)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023)

Overactivated neddylation pathway in human hepatocellular carcinoma
por: Yu, Jian, et al.
Publicado: (2018)

The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues
por: Pang, Yu‐Yan, et al.
Publicado: (2020)

Malic enzyme 2 promotes the progression of hepatocellular carcinoma via increasing triglyceride production
por: Zhang, Shuai, et al.
Publicado: (2021)

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis
por: Li, Xiao-Song, et al.
Publicado: (2020)

The application value of modified thyroid imaging report and data system in diagnosing medullary thyroid carcinoma
por: Zhu, Jialin, et al.
Publicado: (2019)

Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma
por: Fan, Yanfen, et al.
Publicado: (2021)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

The Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Poor Prognosis Factor in Patients with Hepatocellular Carcinoma: An Analysis of Microvessel Density
por: Huang, Chun-Wei, et al.
Publicado: (2022)

T cell receptor repertoire profiling predicts the prognosis of HBV‐associated hepatocellular carcinoma
por: Lin, Kai‐Rong, et al.
Publicado: (2018)

DSCAM‐AS1 regulates the G(1)/S cell cycle transition and is an independent prognostic factor of poor survival in luminal breast cancer patients treated with endocrine therapy
por: Sun, Wei, et al.
Publicado: (2018)

Clinicopathological and prognostic implications of vessels encapsulate tumor clusters with PD-L1 in intrahepatic cholangiocarcinoma patients
por: Tao, Ping, et al.
Publicado: (2020)

Risk factors for upper tract urothelial recurrence following local excision of bladder cancer
por: Lin, Ning, et al.
Publicado: (2018)

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma
por: Lu, Liang-He, et al.
Publicado: (2020)

Application of a Convolutional Neural Network for Multitask Learning to Simultaneously Predict Microvascular Invasion and Vessels that Encapsulate Tumor Clusters in Hepatocellular Carcinoma
por: Chu, Tongjia, et al.
Publicado: (2022)

Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma
por: Deng, Min, et al.
Publicado: (2021)

Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma
por: Ding, Yuan, et al.
Publicado: (2020)

Epithelial-Mesenchymal Transition is Superior to Vessels-Encapsulate Tumor Cluster in Promoting Metastasis of Hepatocellular Carcinoma: a Morphological Evidence
por: He, Chuanchao, et al.
Publicado: (2017)

Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma
por: He, MinKe, et al.
Publicado: (2019)

Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
por: Mei, Jie, et al.
Publicado: (2021)

Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models
por: Zhang, Yong-Fa, et al.
Publicado: (2021)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma
por: Xu, Fei, et al.
Publicado: (2017)

Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma
por: Jiang, Yan‐Ji, et al.
Publicado: (2019)

A signature of 33 immune‐related gene pairs predicts clinical outcome in hepatocellular carcinoma
por: Sun, Xiao‐Yan, et al.
Publicado: (2020)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

NLRC and NLRX gene family mRNA expression and prognostic value in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2017)

mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
por: Feng, Jing, et al.
Publicado: (2020)

The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE
por: Lu, Liang-He, et al.
Publicado: (2021)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b7o0q0mt5dj25csrj9sksbcbsa